FI890050A0 - NYA 3,5-DIHYDROXIKARBONSYROR OCH DERAS DERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING SOM LAEKEMEDEL, PHARMACEUTICAL PREPARAT OCH MELLANPRODUKTER. - Google Patents
NYA 3,5-DIHYDROXIKARBONSYROR OCH DERAS DERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING SOM LAEKEMEDEL, PHARMACEUTICAL PREPARAT OCH MELLANPRODUKTER.Info
- Publication number
- FI890050A0 FI890050A0 FI890050A FI890050A FI890050A0 FI 890050 A0 FI890050 A0 FI 890050A0 FI 890050 A FI890050 A FI 890050A FI 890050 A FI890050 A FI 890050A FI 890050 A0 FI890050 A0 FI 890050A0
- Authority
- FI
- Finland
- Prior art keywords
- deras
- och
- dihydroxikarbonsyror
- nya
- derivat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
- C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/16—Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C49/217—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings
- C07C49/223—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
- C07C49/567—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3800439 | 1988-01-09 | ||
DE3800785A DE3800785A1 (en) | 1988-01-09 | 1988-01-14 | SUBSTITUTED 7- (PYRIDAZIN-5-YL) -3,5-DIHYDROXYHEPTANE (EN) - ACID, YOUR CORRESPONDING (DELTA) -LACTONE OR. DERIVATIVES, PROCESS FOR THEIR PRODUCTION, THEIR USE AS MEDICINAL PRODUCTS, PHARMACEUTICAL PREPARATIONS AND INTERMEDIATE PRODUCTS |
Publications (2)
Publication Number | Publication Date |
---|---|
FI890050A0 true FI890050A0 (en) | 1989-01-05 |
FI890050A FI890050A (en) | 1989-07-10 |
Family
ID=25863830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI890050A FI890050A (en) | 1988-01-09 | 1989-01-05 | NYA 3,5-DIHYDROXIKARBONSYROR OCH DERAS DERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING SOM LAEKEMEDEL, PHARMACEUTICAL PREPARAT OCH MELLANPRODUKTER. |
Country Status (15)
Country | Link |
---|---|
US (1) | US4946841A (en) |
EP (1) | EP0324347A3 (en) |
JP (1) | JPH01213270A (en) |
KR (1) | KR890011859A (en) |
AU (1) | AU612449B2 (en) |
DE (1) | DE3800785A1 (en) |
DK (1) | DK5289A (en) |
FI (1) | FI890050A (en) |
HU (1) | HU202502B (en) |
IL (1) | IL88908A0 (en) |
NO (1) | NO890062L (en) |
NZ (1) | NZ227551A (en) |
PH (1) | PH26148A (en) |
PT (1) | PT89409B (en) |
ZA (1) | ZA89121B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3826814A1 (en) * | 1988-08-06 | 1990-02-08 | Hoechst Ag | NEW 6-FLUORO-3,5-DIHYDROXYCARBONSAEURES AND THEIR DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL PREPARATES AND INTERMEDIATE PRODUCTS |
DE3832570A1 (en) * | 1988-09-24 | 1990-03-29 | Hoechst Ag | 7-SUBSTITUTED DERIVATIVES OF 3,5-DIHYDROXYHEPT-6-ACID, METHODS FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICINAL PRODUCTS AND INTERMEDIATE PRODUCTS |
AU628862B2 (en) * | 1988-10-03 | 1992-09-24 | Glaxo Group Limited | Substituted n-vinyl imidazole derivatives |
IE903606A1 (en) * | 1989-10-10 | 1991-04-24 | Glaxo Group Ltd | Chemical compounds |
IT1237792B (en) * | 1989-12-21 | 1993-06-17 | Zambon Spa | ACTIVE COMPOUNDS AS INHIBITORS OF THE HMG-COA REDUCTASE ENZYME |
JPH054943A (en) * | 1990-08-30 | 1993-01-14 | Sagami Chem Res Center | Optically active beta,delta-diketo-acid ester and reduced material thereof |
DE4208051A1 (en) * | 1992-03-13 | 1993-09-16 | Bayer Ag | SUBSTITUTED PHENYL ACIDIC ACID AMIDE |
DE4208052A1 (en) * | 1992-03-13 | 1993-09-16 | Bayer Ag | IMIDAZOLYL SUBSTITUTED PHENYL ACIDANCE AMIDE |
DE4212796A1 (en) * | 1992-04-16 | 1993-10-21 | Bayer Ag | Propenoyl-imidazole derivatives |
DE4215587A1 (en) * | 1992-05-12 | 1993-11-18 | Bayer Ag | Sulfonylbenzyl-substituted benzo- and pyridopyridones |
DE4215588A1 (en) * | 1992-05-12 | 1993-11-18 | Bayer Ag | Biphenylmethyl-substituted pyridones |
DE4220983A1 (en) * | 1992-06-26 | 1994-01-05 | Bayer Ag | Imidazolyl-substituted phenylpropionic and cinnamic acid derivatives |
DE4319041A1 (en) * | 1992-10-23 | 1994-04-28 | Bayer Ag | Trisubstituted biphenyls |
WO2004094379A2 (en) * | 2003-04-16 | 2004-11-04 | Amgen Inc. | 3-phenyl-4- (pyrimidin-2-yl) -6- (piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations |
US8372877B2 (en) | 2010-04-16 | 2013-02-12 | Cumberland Pharmaceuticals | Stabilized statin formulations |
EP2626069A4 (en) | 2010-10-06 | 2014-03-19 | Univ Tokyo | Prophylactic and/or therapeutic agent against lymphedema |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2752820A1 (en) * | 1977-11-26 | 1979-05-31 | Bayer Ag | NEW NITRO-SUBSTITUTED 1,4-DIHYDROPYRIDINE, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT |
US4375475A (en) * | 1979-08-17 | 1983-03-01 | Merck & Co., Inc. | Substituted pyranone inhibitors of cholesterol synthesis |
US4540796A (en) * | 1982-05-03 | 1985-09-10 | Merck & Co., Inc. | Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase via a chiral synthon |
US4613610A (en) * | 1984-06-22 | 1986-09-23 | Sandoz Pharmaceuticals Corp. | Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives |
KR890001651B1 (en) * | 1984-06-22 | 1989-05-12 | 산도즈 파마슈티칼스 코포레이션 | Process preparing of pyrazoleanalogs and its derivatives of mevalonolactone |
US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
US4735958A (en) * | 1986-12-22 | 1988-04-05 | Warner-Lambert Company | Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis |
US4761419A (en) * | 1987-12-07 | 1988-08-02 | Warner-Lambert Company | 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
DE3826814A1 (en) * | 1988-08-06 | 1990-02-08 | Hoechst Ag | NEW 6-FLUORO-3,5-DIHYDROXYCARBONSAEURES AND THEIR DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL PREPARATES AND INTERMEDIATE PRODUCTS |
-
1988
- 1988-01-14 DE DE3800785A patent/DE3800785A1/en not_active Withdrawn
-
1989
- 1989-01-03 EP EP19890100031 patent/EP0324347A3/en not_active Withdrawn
- 1989-01-05 FI FI890050A patent/FI890050A/en not_active IP Right Cessation
- 1989-01-06 ZA ZA89121A patent/ZA89121B/en unknown
- 1989-01-06 NO NO89890062A patent/NO890062L/en unknown
- 1989-01-06 AU AU27780/89A patent/AU612449B2/en not_active Ceased
- 1989-01-06 US US07/294,096 patent/US4946841A/en not_active Expired - Fee Related
- 1989-01-06 DK DK005289A patent/DK5289A/en not_active Application Discontinuation
- 1989-01-06 PT PT89409A patent/PT89409B/en not_active IP Right Cessation
- 1989-01-06 JP JP64000586A patent/JPH01213270A/en active Pending
- 1989-01-06 NZ NZ227551A patent/NZ227551A/en unknown
- 1989-01-06 HU HU8945A patent/HU202502B/en unknown
- 1989-01-06 PH PH38012A patent/PH26148A/en unknown
- 1989-01-07 KR KR1019890000100A patent/KR890011859A/en unknown
- 1989-01-09 IL IL88908A patent/IL88908A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH01213270A (en) | 1989-08-28 |
PT89409B (en) | 1993-12-31 |
AU612449B2 (en) | 1991-07-11 |
IL88908A0 (en) | 1989-08-15 |
PH26148A (en) | 1992-03-18 |
EP0324347A3 (en) | 1990-12-05 |
DK5289A (en) | 1989-07-10 |
DE3800785A1 (en) | 1989-07-20 |
ZA89121B (en) | 1989-09-27 |
NO890062L (en) | 1989-07-10 |
PT89409A (en) | 1990-02-08 |
HUT50790A (en) | 1990-03-28 |
NO890062D0 (en) | 1989-01-06 |
FI890050A (en) | 1989-07-10 |
NZ227551A (en) | 1990-11-27 |
AU2778089A (en) | 1989-07-13 |
US4946841A (en) | 1990-08-07 |
DK5289D0 (en) | 1989-01-06 |
KR890011859A (en) | 1989-08-23 |
EP0324347A2 (en) | 1989-07-19 |
HU202502B (en) | 1991-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI900313A0 (en) | NYA BENZOPYRANDERIVAT, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PREPARAT. | |
FI901956A0 (en) | NYA NAPHTHALENYLALKYL-3H-1,2,3,5 -OXATIADIAZOLE-2-OXIDER ANVAENDBARA SOM ANTIHYPERGLYCEMICAL MEDEL. | |
FI891227A (en) | KATEKOLDERIVAT OCH PHARMACEUTICAL PREPARAT SOM INNEHAOLLER DESSA. | |
FI890050A (en) | NYA 3,5-DIHYDROXIKARBONSYROR OCH DERAS DERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING SOM LAEKEMEDEL, PHARMACEUTICAL PREPARAT OCH MELLANPRODUKTER. | |
FI914319A0 (en) | NYA KARBOCYKLISKA ADENOSINANALOGER ANVAENDBARA SOM IMMUNOSUPRESSANTER. | |
FI891449A0 (en) | NYA 2,3,4-SUBSTITUERADE IMIDAZOLER OCH 3,4,5-SUBSTITUERADE 1,2,4-TRIAZOLER, DERAS FRAMSTAELLNING OCH ANVAENDNING. | |
FI903739A0 (en) | NYA 5-SUBSTITUERADE-1,3,4-THIADIAZOLER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM BEKAEMPNINGSMEDEL MOT SKADEINSEKTER. | |
FI894629A (en) | NYA 3,4-DIAMINOQUINOLIN- OCH-PYRIDINFOERENINGAR. | |
FI911606A0 (en) | FOERFARANDE FOER FRAMSTAELLNING AV NYA FOERENINGAR, SOM INHIBERAR TROMBOCYTAGGREGATION. | |
FI874020A0 (en) | TETRAHYDROKINOLINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PREPARAT. | |
FI872897A (en) | NYA 4-PYRIDONDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PREPARAT. | |
FI894798A0 (en) | NYA 1,4-BENZOZAZINE- OCH 1,4-BENZOZIAZINDERIVAT OCH FOERFARANDE FOER DERAS FRAMSTAELLNING. | |
FI883251A0 (en) | SUBSTITUTE BENSIMIDAZOLER, FOERFARANDE FOER DERAS FRAMSTAELLNIG, DESSA INNEHAOLLANDE PHARMACEUTICAL PREPARAT OCH DERAS ANVAENDNING. | |
FI915435A0 (en) | NYA LEUKOTRIEN-B4-DERIVATER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL. | |
FI922773A0 (en) | NYA P-SUBSTITUERADE FENYL-4-OXYBUTANAMINDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLLNING SAMT PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DESAMMA. | |
FI904191A0 (en) | NYA AMINOPROPANOLDERIVATER, FOERFARANDE FOER TILLVERKNING AV DESSA SAMT PHARMACEUTICAL SAMMANSAETTNINGAR SOM INNEHAOLLER DESSA. | |
FI892897A0 (en) | NYA KONDENSERADE DIAZEPINONER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH CEEKEMEDEL SOM INNEHAOLLER DESSA FOERENINGAR. | |
FI903237A0 (en) | FENOXIPYRIDINAMINER OCH DERAS DERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL. | |
FI900661A0 (en) | NYA FORMBARA SAMMANSAETTNINGAR SOM HAERDAS I VAERME. | |
FI894758A (en) | DERIVAT AV 3-ARYLOXIMETYL -CEFALOSPORIN, DERAS FRAMSTAELLNING OCH MEDICINSKA ANVAENDNING. | |
FI892896A0 (en) | NYA KONDENSERADE DIAZEPINONER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH CEEKEMEDEL SOM INNEHAOLLER DESSA FOERENINGAR. | |
FI880357A0 (en) | NYA ISOXAZOLDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE FARMACEUTISKA PREPARAT. | |
FI932034A0 (en) | NYA 1-AZACYCLOALKANDERIVAT, PHARMACEUTICAL SAMMANSAETTNINGAR SOM INNEHAOLLER DESSA SAMT FOERFARANDE FOER FRAMSTAELLNING DAERAV | |
FI895899A0 (en) | NYA TROMBOLYTISKA PROTEINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA SOM AKTIVAEMNE INNEHAOLLANDE CEEKEMEDEL. | |
FI894347A (en) | 2,3,4,5-TETRAHYDRO-1-BENZOXEPINER, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING OCH DESSA FOERENINGAR INNEHAOLLANDE PHARMACEUTICAL PREPARAT. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
MM | Patent lapsed |
Owner name: HOECHST AKTIENGESELLSCHAFT |